Pre-market hot trades in US stocks: Corning fell 3.06% in pre-market trading, with a double blow to its stock price from executive sell-offs and limited AI demand

Pre-market Hot Trades in US Stocks Corning fell 3.06% in pre-market trading. Based on recent key news: On March 16, comments from the CEO of Broadcom negatively impacted market sentiment, suggesting limited short-term potential for optical networks in AI data centers, which may reduce demand for Corning's core optical communication products. This news put pressure on Corning's stock price. On March 11, a large-scale stock sale by Corning executives at the end of February raised internal concerns about the company's future performance. This move was seen as a potential negative signal for the company's future results, further exacerbating stock price volatility. Supply chain constraints and timing issues continue to hinder Corning's ability to fully capitalize on the growing demand for optical solutions in the AI infrastructure market. Analysts' "D" rating on the company's valuation makes it susceptible to severe adjustments during poor performance or operational missteps. The demand for AI infrastructure is growing, with significant supply chain constraints. Top Gainers in Pre-market US Stocks Lunai Bioworks rose 65.50% in pre-market trading, with no significant recent news. The trading is active, and the capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. AEye rose 36.77% in pre-market trading. Based on recent key news: On March 16, AEye announced its participation in the NVIDIA Halos AI System Detection Laboratory, aimed at advancing safety-certified physical AI solutions. This collaboration enhanced AEye's position in industry-standard safety practices, driving the stock price up. Source: Reuters On March 16, AEye released its fourth-quarter financial report, showing an operating loss but a 15% year-over-year revenue increase, with cash flow supporting operations until 2028, boosting market confidence. Source: AEye SEC announcement On March 16, analysts rated AEye as "Buy," predicting a 12-month target price of $6, indicating significant upside potential from the current stock price, further driving the stock price up. Source: Reuters The overall outlook for the electronic equipment industry is bullish, with noticeable capital inflow. Neuronetics rose 21.32% in pre-market trading. Based on recent news: On March 16, Neuronetics announced that its deep brain stimulation system won first place in the 2025 National Disruptive Technology Innovation Competition and completed four clinical research implantation surgeries. This news significantly boosted market confidence in its future development, driving the stock price up. On March 16, Neuronetics' deep brain stimulation system is set to begin clinical trials in 2027, providing disruptive treatment options for patients with Parkinson's disease, epilepsy, and more. The announcement of this plan further enhanced investor confidence, leading to a substantial increase in stock price. On March 16, Neuronetics received joint investments from Tencent and Alibaba, marking a deep layout by internet and technology giants in the brain-computer interface field This news is interpreted by the market as strong support for Neuronetics' future development, driving a significant increase in stock prices. The brain-computer interface field is ushering in an unprecedented historical opportunity